These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11334136)

  • 1. Acute psychosis after CPAP treatment in a schizophrenic patient with sleep apnoea-hypopnoea syndrome.
    Chiner E; Arriero JM; Signes-Costa J; Marco J
    Eur Respir J; 2001 Feb; 17(2):313-5. PubMed ID: 11334136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compliance with CPAP therapy in patients with the sleep apnoea/hypopnoea syndrome.
    Engleman HM; Martin SE; Douglas NJ
    Thorax; 1994 Mar; 49(3):263-6. PubMed ID: 8202884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome.
    Engleman HM; Martin SE; Deary IJ; Douglas NJ
    Lancet; 1994 Mar; 343(8897):572-5. PubMed ID: 7906330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic continuous positive airway pressure (CPAP) therapy on upper airway size in patients with sleep apnoea/hypopnoea syndrome.
    Mortimore IL; Kochhar P; Douglas NJ
    Thorax; 1996 Feb; 51(2):190-2. PubMed ID: 8711654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal continuous positive airway pressure with supplemental oxygen in coexistent sleep apnoea-hypopnoea syndrome and severe chronic obstructive pulmonary disease.
    Sampol G; Sagalés MT; Roca A; de la Calzada MD; Bofill JM; Morell F
    Eur Respir J; 1996 Jan; 9(1):111-6. PubMed ID: 8834343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous positive airway pressure for sleep apnoea/hypopnoea syndrome: usefulness of a 2 week trial to identify factors associated with long term use.
    Popescu G; Latham M; Allgar V; Elliott MW
    Thorax; 2001 Sep; 56(9):727-33. PubMed ID: 11514695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partners of patients with sleep apnoea/hypopnoea syndrome: effect of CPAP treatment on sleep quality and quality of life.
    McArdle N; Kingshott R; Engleman HM; Mackay TW; Douglas NJ
    Thorax; 2001 Jul; 56(7):513-8. PubMed ID: 11413348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome.
    Engleman HM; Martin SE; Kingshott RN; Mackay TW; Deary IJ; Douglas NJ
    Thorax; 1998 May; 53(5):341-5. PubMed ID: 9708223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome.
    Engleman HM; Martin SE; Deary IJ; Douglas NJ
    Thorax; 1997 Feb; 52(2):114-9. PubMed ID: 9059469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of correction of flow limitation on continuous positive airway pressure efficiency in sleep apnoea/hypopnoea syndrome.
    Meurice JC; Paquereau J; Denjean A; Patte F; Series F
    Eur Respir J; 1998 May; 11(5):1121-7. PubMed ID: 9648966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adequacy of prescribing nasal continuous positive airway pressure therapy for the sleep apnoea/hypopnoea syndrome on the basis of night time respiratory recording variables.
    Montserrat JM; Alarcón A; Lloberes P; Ballester E; Fornas C; Rodriguez-Roisin R
    Thorax; 1995 Sep; 50(9):969-71. PubMed ID: 8539677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of nose and face mask CPAP therapy for sleep apnoea.
    Mortimore IL; Whittle AT; Douglas NJ
    Thorax; 1998 Apr; 53(4):290-2. PubMed ID: 9741373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Under reporting of sleepiness and driving impairment in patients with sleep apnoea/hypopnoea syndrome.
    Engleman HM; Hirst WS; Douglas NJ
    J Sleep Res; 1997 Dec; 6(4):272-5. PubMed ID: 9493528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment.
    Marti S; Sampol G; Muñoz X; Torres F; Roca A; Lloberes P; Sagalés T; Quesada P; Morell F
    Eur Respir J; 2002 Dec; 20(6):1511-8. PubMed ID: 12503712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of moderate alcohol consumption on obstructive sleep apnoea with and without AutoSet nasal CPAP therapy.
    Teschler H; Berthon-Jones M; Wessendorf T; Meyer HJ; Konietzko N
    Eur Respir J; 1996 Nov; 9(11):2371-7. PubMed ID: 8947088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Split-night versus full-night studies for sleep apnoea/hypopnoea syndrome.
    McArdle N; Grove A; Devereux G; Mackay-Brown L; Mackay T; Douglas NJ
    Eur Respir J; 2000 Apr; 15(4):670-5. PubMed ID: 10780757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of CPAP on daytime functioning in patients with sleep apnoea syndrome.
    Muñoz A; Mayoralas LR; Barbé F; Pericás J; Agusti AG
    Eur Respir J; 2000 Apr; 15(4):676-81. PubMed ID: 10780758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute delirium as a manifestation of obstructive sleep apnea syndrome.
    Muñoz X; Martí S; Sumalla J; Bosch J; Sampol G
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1306-7. PubMed ID: 9769297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health utilities in evaluating intervention in the sleep apnoea/hypopnoea syndrome.
    Chakravorty I; Cayton RM; Szczepura A
    Eur Respir J; 2002 Nov; 20(5):1233-8. PubMed ID: 12449179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of nasal obstruction on auto-CPAP behaviour during sleep in sleep apnoea/hypopnoea syndrome.
    Lafond C; Sériès F
    Thorax; 1998 Sep; 53(9):780-3. PubMed ID: 10319061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.